Loss of GABAergic inhibition in pain pathways has been considered to be a key component in the development of chronic pain. In the present study, we intended to examine whether miR-92b-mediated posttranscriptional dysregulation of spinal potassium chloride cotransporter (KCC2) and vesicular g-aminobutyric acid transporter (VGAT) plays a major role in the development and maintenance of long-term visceral hyperalgesia in neonatal zymosan-treated rats. Neonatal cystitis was induced by transurethral zymosan administration from postnatal (P) days 14 to 16 (protocol 1). Two other zymosan protocols were also used: adult rechallenge on P57 to 59 following neonatal P14 to 16 exposures (protocol 2), and adult zymosan exposures on P57 to 59 (protocol 3). Both neonatal and adult bladder inflammation protocols demonstrated an increase in spinal miR-92b-3p expression and subsequent decrease in KCC2 and VGAT expression in spinal dorsal horn neurons. In situ hybridization demonstrated a significant upregulation of miR-92b-3p in the spinal dorsal horn neurons of neonatal cystitis rats compared with saline-treated controls. In dual in situ hybridization and immunohistochemistry studies, we further demonstrated coexpression of miR-92b-3p with targets KCC2 and VGAT in spinal dorsal horn neurons, emphasizing a possible regulatory role both at pre-and post-synaptic levels. Intrathecal administration of lentiviral pLSyn-miR-92b-3p sponge (miR-92b-3p inhibitor) upregulated KCC2 and VGAT expression in spinal dorsal horn neurons. In behavioral studies, intrathecal administration of lentiviral miR-92b-3p sponge attenuated an increase in visceromotor responses and referred viscerosomatic hypersensitivity following the induction of cystitis. These findings indicate that miR-92b-3p-mediated posttranscriptional regulation of spinal GABAergic system plays an important role in sensory pathophysiology of zymosan-induced cystitis.
Introduction
The neonatal period is a critical time for the development of the nociceptive neural pathways. Any alteration in the level of neuronal activity during this time may affect normal development. The intrinsic mechanism of early-life noxious stimuli-induced permanent alteration in nociceptive processing is not fully understood. It has been proposed that midbrain (rostral ventromedial medulla) descending inhibitory and facilitatory systems, which are involved in modulating pain behavior, are possibly affected. 26 Impairment of the opioid inhibitory pathway has been implicated in the development of painful bladder in animals that have experienced bladder inflammation early in life. 6 In conjunction with these findings, we have recently reported a long-term visceral hyperalgesia and overexpression of spinal N-methyl-D-aspartate receptor subunit NR1 in adult rats following neonatally-induced cystitis. 17 We have also documented that microRNA (miRNA)-mediated posttranscriptional dysregulation of GABA A-a1 receptor subunit expression in the lumbosacral (LS) spinal cord could play a role in the pathophysiology of cystitis-induced visceral pain. 35 The g-aminobutyric acid (GABA) plays a major role in pain modulation in the spinal cord and its function is critically dependent on the activity of intracellular Cl 2 regulatory proteins, such as the inwardly directed NKCC1 and outwardly directed potassium chloride cotransporter (KCC2). 7, 25, 32 Under normal conditions, KCC2 is essential for the maintenance of low intracellular Cl 2 concentrations in mature neurons and the hyperpolarizing function of GABA in the spinal cord. 5, 27 In certain pathological conditions, such as in diabetic neuropathy, KCC2 is downregulated or becomes nonfunctional leading to high intracellular loading of Cl
2
. In such conditions, the opening of GABA A receptor channels results in a rapid efflux of Cl 2 because of the reversed concentration gradient, which results in depolarization and neuron hyperexcitation. 9, 20, 21 Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Unlike in adult pain models, where the loss of GABAergic function is observed to be transient, the neonatal cystitis-induced rats have shown a long-lasting visceral hyperalgesia and downregulation of spinal GABA A receptor expression when tested in adulthood. 35 This finding indicates that following early-in-life insults, there could be a permanent impairment of developing GABAergic neurotransmission that might contribute towards its disinhibition and development of chronic pelvic pain (CPP) later in life.
The involvement of miRNAs in chronic visceral pain, including painful bladder syndrome (PBS) and irritable bowel syndrome (IBS), has recently been reported. 4, 18, 31, 42 We have previously demonstrated upregulations of several spinal miRNAs, including miR-92b in rats treated with zymosan early in life. 35 Interestingly, miR-92b target gene prediction suggests several GABA-associated genes, including KCC2 and vesicular GABA transporter (VGAT). These findings encouraged us to investigate the involvement of miR92b-mediated posttranscriptional dysregulation of spinal GABAergic transmission in the pathophysiology of zymosan-induced cystitis and CPP. Therefore, in the present study, we intended to examine whether (1) intravesicle zymosan treatment both at neonatal and adult stages affect the expression of miR-92b and its target genes, KCC2 and VGAT, in LS spinal dorsal horn neurons and (2) miR-92b-mediated posttranscriptional deregulation of GABAergic transmission is the underlying mechanism for the development and maintenance of long-term visceral hyperalgesia following early-in-life cystitis in rats.
Materials and methods

Animals
Female Sprague-Dawley rats weighing 200 to 250 g were used for this study. For neonatal treatment, time-pregnant rats were purchased from Taconic Farms (Cambridge City, IN) and maintained in separate cages. All animals were housed under controlled conditions with a 12-hour light-dark cycle and had free access to food and water. The pups were kept with their mother until weaning occurred on P21. The experiments were performed according to the approved guidelines by the Institutional Animal Care and Use Committee at the Medical College of Wisconsin (AUA355) and followed the humane pain management recommendation of the IASP.
Zymosan-induced cystitis in neonate and adult rats
Three different zymosan treatment protocols were used in this study (Fig. 1A) . In protocol 1 (neonatal treatment), 2 groups of female pups, experimental and control groups, received transurethral zymosan (1% in saline, 100 mL) and saline (100 mL), respectively, from postnatal (P) days 14 through 16. In protocol 2 (neonatal treatment and adult rechallenge), neonatal rats received zymosan treatment as mentioned in protocol 1 followed by adult zymosan-or saline-rechallenge in adulthood from P57 through 59. In protocol 3 (adult treatment), rats in experimental and control groups received zymosan and saline, respectively, from P57 through 59. In all 3 protocols, rats were euthanized at P60 and tissues were obtained for analysis.
Bladder histology
The extent of bladder damage following zymosan treatment in each protocol was assessed by hematoxylin and eosin staining. Histological examination was performed by a pathologist blinded to the groups and treatment protocols. Different degrees of epithelial loss (eg, splitting, erosion, and ulceration), reactive epithelial changes (eg, basal hyperplasia, edema, congestion, bleeding, and vessel's lesions) and inflammation (polymorphonuclear leukocytes, lymphocytes) among the groups were scored. The histological scoring was undertaken based on the following 3 criteria: staining with no inflammatory cell infiltration and minimal erosion and ulceration was scored as (2); staining pattern with a very few inflammatory cell infiltration and low level of edema and vascular congestion was scored as (1); significant infiltration, vascular congestion, and erosion was scored as (11/111). To provide numerical scorings for the histological evaluation, the grading (2) was assigned a numerical value of 0, grading (1) with value of 1 and gradings (11) and (111) of values 2 and 3, respectively. The histological scorings between the groups were compared using the Student t test and presented as mean 6 SD, and values with p , 0.05 were considered to be significant.
Total RNA extraction and Qiagen microRNA PCR Array
Total RNA from the dorsal region of the spinal cord (L6-S1) of each rat was isolated using Trizol (Thermo Fisher Scientific, Waltham, MA) according to the manufacturers' instructions. RNA concentration was measured with NanoDrop (Thermo Fisher Scientific). Total RNA was reverse transcribed using miScript II RT Kit (Qiagen, Valencia, CA). The complementary DNA (cDNA) obtained was used as the template in miScript PreAMP PCR Kit with miScript PreAMP pathway primer mixture (MBRN-120Z, Qiagen). Five preAmp samples within each group were pooled to use for miRNA PCR Array. We used the Rat Pain miScript miRNA PCR Array (Neuropathic & Inflammatory miScript miRNAs PCR Array, MIRN-120Z, Qiagen) representing 84 miRNAs known to be involved in the transduction, maintenance, and modulation of pain responses for analyzing miRNA expression profiles in the spinal dorsal horn samples. These miRNAs were selected based on the existing literature reporting their differential expressions in various rodent models of neuropathic and inflammatory pain. The PCR Array reactions were prepared based on the Qiagen protocol using QuantiTect SYBR Green PCR Master Mix (Qiagen). A set of controls were incorporated in each array for proper data analysis using the ΔΔC T method of relative quantification and for the assessment of reverse transcription (RT) and PCR performance. Values of cycle threshold (C T ) obtained for individual miRNAs in the array were uploaded to the Qiagen website for the calculation of fold changes in neonatal cystitis samples compared with saline controls. SNORD-95 was chosen from the group of 5 housekeeping genes as the best and least varying reference gene.
Validation of microRNA PCR array results by real-time quantitative reverse transcription PCR
Real-time quantitative RT-PCR was performed to validate the miRNA PCR array results. Total RNA from individual spinal dorsal horn tissues (500 ng) was reverse transcribed using RT 2 -first strand kit from Qiagen. The real-time PCR was performed using the RT 2 -PCR Primer Assay kit and RT 2 -SYBR Green master mixes from Qiagen. Individual cDNA preparations (n 5 5-6/group) were used, and results were expressed as relative miRNA expression in terms of C T values in relation to the amount of reference miRNA expression using the formula 5 2 2 ðC T miRNA 2 C T SNORD 2 95Þ .
all miRNA targets predicted by TargetScan Human v5.1, MicroCosm Targets v5, miRDB v3, TarBase v.5c, miRecordsv2, DIANA-microT v3.0, RNA22, and PITA v6. 16 Targets predicted by 3 algorithms were selected for further study.
39UTR gene constructs and luciferase assay
To confirm that the expressions of KCC2 and VGAT genes are regulated by complimentary binding of their 39-UTRs by miR-92b-3p, we constructed 2 pEZX-MT06 vectors carrying 39UTRs of KCC2 (2088 bp) and VGAT (728 bp) mRNAs, respectively, fused downstream of firefly luciferase reporter gene hLuc under SV40 promoter (GeneCopoeia, Rockville, MD). pEZX-MT06 carries dual reporters including one for regulatory detection (firefly) and another for the internal control and signal normalization (Renilla). To determine the optimal concentrations of plasmids and oligonucleotides suitable for luciferase assay, HEK293T cells were cotransfected with plasmids (100 or 200 nM) along with several concentrations of MIRDIAN miR-92b mimic or MIRIDIAN miRNA mimic negative control ranging from 50 to 200 nM (GE Pharmakon, Lafayette, CO). Because the control miRNAs at higher concentrations of 200 nM demonstrated an inhibitory effect on HEK293 cells, we selected a lower concentration of 100 nM for both the plasmids and oligonucleotides for the transfection study. The cell transfection was performed in serum-free medium using 1% lipofectamine 2000 according to the manufacturer's protocol (Thermo Fisher Scientific). Cells were lysed 24 hours after transfection, and luciferase activity was measured using a Dual-Luciferase Reporter Assay kit (Promega, Madison, WI). The change in dualluciferase activity of the transfected cells in the same well was measured using GloMax 20/20 Luminometer (Promega, Madison, WI) and presented as normalized firefly luciferase activity against Renilla activity. Three independent transfection experiments were performed for miR-92b-3p mimic and control miRNA using construct carrying either KCC2 or VGAT 39UTR. The results were expressed as percent reduction of luciferase activity in miR-92b-3p transfected cells in relation to 100% activity for cells transfected with only plasmid carrying 39UTR of either KCC2 or VGAT.
2.8. miR-92b-3p expression in spinal dorsal horn neurons (L6-S1) using in situ hybridization (ISH)
All surgical equipment and reagents were made RNAase-free before conducting ISH. Rats were deeply anesthetized with pentobarbital sodium (50 mg/kg, i.p.) and perfused transcardially with cold (4˚C) phosphate buffer solution followed by perfusion with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS), pH 7.4. The L6-S1 segments of the spinal cords were collected and incubated in 4% paraformaldehyde overnight at 4˚C followed by incubation overnight in 20% sucrose made in 0.1 M PBS. The tissues were then embedded in HistoPrep (Thermo Fisher Scientific, Pittsburgh, PA), and serial sections of 30-mm thickness were taken using a cryostat. The spinal cord sections were then subjected to proteinase K digestion (1 mg/mL, Exiqon, Woburn, MA) for 10 minutes at 37˚C, followed by prehybridization in microRNA ISH hybridization buffer (Exiqon) for 2 hours at 55˚C. The hybridization with miRCURY LNA-double DIG detection probe hsa-miR-92b-3p (Exiqon, 59-DIG-AGGCCGGG-CGAGTG-CAATA-DIG-39) and the negative control (59DIG-GTGTAA-CACGTCTATA-CGCCCA-DIG-39) was performed overnight at 55˚C. After several washes with prehybridization buffer containing various percentages of saline sodium citrate and finally with PBST (PBS 1 0.1% Tween 20), tissues were incubated in ISH blocking buffer (10% sheep serum 1 PBST) for 2 hours. This step was followed by incubation with anti-digoxigenin-fluorescence (1:500, Roche, Indianapolis, IN) for 2 hours at room temperature.
After final washings, slides were examined under a fluorescent microscope (Nikon Eclipse 50i, Nikon Instruments Inc, Melville, NY) using narrow band cubes for Alexa 488 (DM505, excitation filter 470-490, barrier filter 515-550 nm). Images were captured with a Nikon Sight DS-Fi1 high-resolution digital camera and processed using Adobe Photoshop CS6 program. To maintain the consistency of image capturing, we used the same time of exposure, gain, and gamma adjustment for the control and experimental samples. Images were then opened in ImageJ program (NIH, Bethesda, MD), and the free hand tool was used to trace the outline of each cell. The fluorescence images were converted into gray mode. Arbitrary gray scale units (in the range of 1-255) were assigned to quantify the intensity of staining of a given cell. The nonspecific background staining was measured in a similar way by selecting cells with staining below the threshold limit for differentiating positively stained cells. We selected 1 section per animal from both neonatal zymosan-and salinetreated groups, and only cells containing a darker nucleus were selected for analysis. Intensity of staining for 5 to 10 cells per section was measured, and the average intensity of staining from 3 sections per group was determined. The cell counts were performed by an investigator blinded to the experimental conditions. The mean intensity of staining from zymosantreated rats was compared with that of saline-treated controls using the Student t test and presented as mean 6 SD, and values with P , 0.05 were considered to be significant.
KCC2 (Slc12a5) and VGAT (Slc31a1) gene expression in spinal dorsal horn neurons (L6-S1) by quantitative reverse transcription PCR
Total RNA was extracted from individual spinal dorsal horn sample (L6-S1) from rats receiving 3 different treatment protocols (Fig. 1A) using TRIzol (Thermo Fisher Scientific). The RT for individual sample was performed with iScript cDNA synthesis kit (Bio-Rad, Richmond, CA) in iCycler (Bio-Rad) using 500 ng total RNA from each sample. Real-time PCR was performed using iQ SYBR Green Supermix (Bio-Rad) in a total volume of 25 mL of reaction mixture containing 5 pmol forward and reverse primers and 2 mL cDNA preparation as the template. The primers used for KCC2 were as follows (sense): 59-GTTCCCGAAGAGACAGCTTG-39 and (antisense) 59-GAGCCGCTGACTTATCCTTG-39. The primers for VGAT were as follows (sense): 59-TTCCTATCTCCATCGGCATC-39 and (antisense): 59-ATCCGTGATGACTTCCTTGG-39. Primers for reference gene ribosomal RNA were as follows (sense): 59 GACCATAAACGAT-GCCGACT 39 and (antisense); 59-GTGAGGTTTCCCGTGTTGAG-39 (IDT, Coralville, IA). The C T values for ribosomal RNA were highly reproducible between samples and between PCR reactions. Although we usually considered C T values less than 35 as specific amplification, C T values for both KCC2 and VGAT genes in experimental and control groups were in the range of 22 to 26 in this study. A no template control PCR reaction was run as a negative control. cDNA preparations (n 5 5-6/group) were used, and results were expressed as relative mRNA expression in terms of C T values in relation to the amount of reference gene mRNA expression using the formula 5 2 2 ðC T target 2 C T rRNAÞ .
KCC2 and VGAT protein expression in spinal dorsal horn neurons (L6-S1) by Western blot analysis
Western blot analysis was performed to investigate the long-term KCC2 and VGAT protein expression in spinal dorsal horns samples from adult rats (P60) following neonatal zymosan/saline treatments at P14-P16. The method used for Western blot analysis was as described in our previous publication. 35 In brief, approximately 10 to 25 mg of spinal tissue extracts were electrophoresed by 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. After transfer, the membranes were blocked with 5% nonfat milk and then incubated separately with rabbit anti-KCC2 (1:500; Millipore, Billerica, MA) and rabbit anti-VGAT (1:250, Alomone Labs, Jerusalem, Israel) overnight at 4˚C. The membranes were then treated with secondary antibody horseradish peroxidase-conjugated goat antirabbit antibody (1:5000, Jackson Immuno-Research, West Grove, PA) for 2 hours at room temperature. The antigen-antibody reaction was visualized using an enhanced chemiluminescent detection system (Thermo Fisher Scientific). The expression for KCC2 and VGAT was normalized against the expression of the housekeeping gene b-actin for the same tissue samples using NIH ImageJ software. The relative intensity of expression against b-actin was compared between the groups (n 5 3/group) using the Student's t test and presented as mean 6 SD. Values with P , 0.05 were considered to be significant.
In situ hybridization and immunohistochemical (IHC)
staining of spinal cords (L6-S1) for dual expression of miR92b-3p and GABA-associated pre-and postsynaptic proteins
For dual ISH and IHC staining, we first performed miR-92b-3p probe hybridization as mentioned in the ISH protocol of the Method section 2.8. After completing the treatment with antidigoxigenin-fluorescence (1:500, Roche) for 2 hours at room temperature, spinal cord tissue sections were incubated overnight with either one of the following antibodies at 1:100 dilution, rabbit anti-KCC2 (Millipore), rabbit anti-VGAT (Alomone Labs), and rabbit anti-GABA A-a1 (Alomone Labs). The tissue sections were then incubated with secondary antibody goat anti-rabbit Alexa 568 (1:500, Molecular Probes, Thermo Fisher Scientific). Slides were examined under an upright Olympus Fluoview FV1000MPE microscope (Olympus, Waltham, Massachusetts) running FV-ASW10 (version 04.02.02.09) and equipped with a 360 objective.
Surgical procedure
The implantation of electromyography (EMG) recording electrodes and catheter were performed in rats under deep anesthesia by injecting sodium pentobarbital (50 mg/kg, i.p.). A pair of tefloncoated electrodes (Conner Wire, Part No. A5631, Chatsworth, CA, USA) were implanted into the external oblique muscle of the abdomen and externalized through the neck. 10 For intrathecal (i. t.) lentivirus injection at L6-S1 segment of the spinal cord, a polyethylene catheter was chronically implanted into the epidural space as reported previously. 3 All surgical procedures were performed 1 week (P54) before administration of i.t. lentiviral miR-92b-3p sponge or scramble miRNA into the animals.
2.13. Neuron-specific lentiviral miR-92b-3p sponge for in vivo transfection of spinal neurons miRNA sponge lentivirus with 6 inhibitor sequences was generated for mmu-miR-92b-3p (Accession: mmu-miR-92b-3p), and the sponge miR-92b-3p sequence was verified by PCR amplification (Creative Biogene, Shirley, NY). miR-92b-3p sponge and the control scramble miRNA sequences were then cloned under neuron-specific promoter synapsin 1 in lentiviral expression vector, which also expressed green fluorescent protein (GFP) under cytomegalovirus promoter. A viral titer of 1 3 10 9 infection forming units was used for our in vivo study. For behavioral studies, 3 groups of adult rats at P60 were used, and a schematic representation of the lentivirus treatment protocol is shown in Figure 1B . The baseline visceromotor response (VMR) and von Frey withdrawal reflex were performed for all animals before the induction of cystitis. As shown in Figure 1B , rats in groups 2 and 3 received i.t. administration (L6-S1 region) of pLSyn miR-92b-3p sponge and pLSyn scramble miRNA, respectively (3 mL of 1 3 10 9 infection forming units lentivirus/mL along with 1.5 mL of 20 ng/mL polybrene) for 3 consecutive days. Following a 2-week interval after lentivirus treatment, all 3 groups received intravesical zymosan treatment for 3 consecutive days. The VMR to colorectal distension (CRD) and von Frey probed withdrawal reflex were recorded 24 hours after the last zymosan treatment to evaluate the effect of miR-92b-3p sponge on the development of visceral hyperalgesia following the induction of cystitis.
Visceromotor response recording to colon distension
Seventy-two hours after the surgery, rats were placed inside plexiglass restraining tubes 2 times a day for 2 hours (1 hr/ session) to acclimate them to experimental conditions. The increase in EMG activity to CRD was used as an objective measure of visceral sensation and mentioned as VMR. Isobaric graded (constant pressure) distensions (10, 20, 30, 40 , and 60 mmHg for 30 seconds duration) were delivered with a 180-second interstimulus interval. For rats in 3 groups, baseline VMR to graded CRD was carried out before zymosan administration. The procedure was repeated after zymosan treatment for each animal in all 3 groups. In each rat, the EMG activity to CRD was measured as the area under the curve, and the value was normalized to maximum response at distending pressure of 60 mmHg.
Abdominal referral responses to mechanical probing
Abdominal muscle tender pain was measured in all rats of 3 protocols. This subjective measurement was performed using the assessment method described previously. 13 Briefly, calibrated von Frey filaments were used to test the referred somatic pain of suprapubic muscle tenderness to mechanical probing. Individual rats were placed in a lucite cubicle with a wire mesh bottom and were given 10 minutes to acclimate before testing. A series of 8 monofilaments with different forces in grams (0.02, 0.07, 0.17, 1.19, 2.05, 5.50, 11.70, and 29.00) were applied to the suprapubic region of the abdomen. Each monofilament was applied 10 times as a 1 to 2 second stimulus with an interval of approximately 10 seconds between each stimulus. The number of withdrawal responses divided by a total of 10 trials for each monofilament was recorded as the response frequency. A sharp retraction of the abdomen, licking/scratching, and jumping were considered as withdrawal responses.
Identification and characterization of green fluorescent protein-positive spinal cords (L6-S1) neurons for KCC2 and VGAT expression following lentivirus treatment
Spinal cord (L6-S1) tissues from both lentivirus sponge-and scramble-treated rats were collected following behavioral recordings to examine the effect of the treatment on the neuronal expression of KCC2 and VGAT. To ensure the simultaneous detection of the pre-and post-synaptic proteins and also to limit the epitope masking after tissue fixation, we performed a brief tissue fixation with 4% paraformaldehyde for 45 minutes, and the tissues were processed for immunostaining within 24 hours following fixation. 33 Spinal cord tissue sections were incubated overnight with rabbit anti-GFP antibody (1:100 Cell Signaling) along with either mouse anti-KCC2 (1:100, Abcam, Cambridge, MA) or mouse anti-VGAT (1:1000, Synaptic System, GmbH, Gottingen, Germany). The tissue sections were then incubated with secondary antibody donkey anti-rabbit Alexa 488 (1:500, Molecular Probes) and goat anti-mouse Alexa 568 (1:2000, Molecular Probes). Slides were examined by laser confocal microscope (Olympus) equipped with a 360 and 3100 objectives. For image analysis, the spinal regions of laminae I to III were selected from both the sponge-and scramble-treated rats. For evaluating the neuron-specific alteration, we selected neurons positive for synapsin 1-induced GFP expression. We used similar settings of exposure, gain, and gamma adjustment for capturing images from both sponge-and scramble-treated animals. From each section, a set of z-series were acquired from the laminae I to III from 1 dorsal horn with each series consisting of 10 optical sections 0.5 m apart. The individual GFP-positive cells were selected, and intensity of membrane KCC2 expression was measured using the ImageJ program. For quantifying the intensity of staining, 3 animals from each group were used, and the average intensity of staining from 3 sections per group was determined. The mean intensity of staining from the sponge lentivirus-treated rats was compared with scramble virus-treated controls using the Student t test and presented as mean 6 SD, and values with P , 0.05 were considered to be significant.
For VGAT immunostaining for each tissue section, a single optical section (the fifth in the z-series) was viewed using the ImageJ program. We selected a fixed region of interest (ROI) encompassing individual GFP-positive cells to count VGAT-stained puncta in tissue sections from both sponge-and scramble-treated rats. Three to 4 ROIs per section were selected for counting the number of VGAT-positive puncta. Three animals from each group were used and the average intensity of staining from 3 sections per group was determined. The average number of VGAT-positive puncta between the groups was compared using the Student t test and presented as mean 6 SD, and values with P , 0.05 were considered to be significant.
Statistics
Reverse transcription PCR data were analyzed by 2-way ANOVA (with protocol and treatment as factors), and followed by all pairwise multiple comparison tests using the HolmSidak method. The von Frey and VMR data were normalized by subtracting the pretreatment values from posttreatment values and then reanalyzed using 2-way repeated measures ANOVA (with treatment and force/CRD as factors). P value ,0.05 was considered significant. Results are expressed as mean 6 SEM.
Results
Histological assessment of bladder inflammation
As reported previously, no significant changes were observed in bladder histology in neonatal zymosan-treated rats as compared to saline controls (Figs. 1C and D) . 17 However, adult zymosan-treated rats exhibited moderate infiltration and lymphocyte aggregation as compared to saline-treated controls. By contrast, neonatal zymosan-treated rats rechallenged with zymosan in adulthood (ie protocol 2 rats) exhibited the most prominent tissue histology, with significantly higher neutrophilic infiltration, vascular congestion, and edema of lamina propria as compared to only adult zymosan treatment (Fig. 1D, p, 0.05). 3.2. Expression, validation, and target gene prediction of differentially expressed miRNAs in L6-S1 spinal cord of neonatally zymosan-treated rats
In this study, we examined the effect of neonatally induced cystitis on spinal miRNA expression using miRNA PCR Array from Qiagen representing miRNAs that are reported to be involved in the transduction, modulation, and maintenance of pain responses in various models of neuropathic and inflammatory pain. In PCR arrays representing 84 miRNAs involved in neuropathic and inflammatory pathways, 11 miRNAs (miR-100-5p, miR-203a-3p, miR-208a-3p, miR-210-3p, miR-214-3p, miR-463-3p, miR-466d, miR-665, miR-742-3p, miR-760-5p, and miR-92b-3p) demonstrated 2-to 6-fold upregulation, and 2 (miR-223-3p and miR-133a-3p) demonstrated 2-fold downregulation in the neonatal cystitis group compared with the saline controls ( Fig. 2A) . To validate PCR array results, quantitative RT- PCR was performed for the differentially expressed miRNAs using individual spinal dorsal horn samples (L6-S1) from both neonatal zymosan-treated and saline-treated controls (Fig. 2B) . Among the upregulated miRNAs in PCR array, the relative expression (2 2 DC T ) of 5 miRNAs was significantly higher in neonatal cystitis rats, for miR-466d, miR-742-3p, and miR-92b-3p, *p , 0.05 and for miR-203a-3p and miR-760-5p, **p , 0.01 vs saline-treated rats; whereas among the downregulated miRNAs in PCR array, the relative expression (2 2 DC T ) of miR-223-3p in neonatal cystitis group exhibited a trend towards downregulation compared with saline-treated controls (p 5 0.06). Therefore, quantitative RT-PCR analysis of the miRNA expression profiles in individual samples validated the results obtained by PCR arrays of pooled samples in experimental and control groups.
The validated miRNAs were then subjected to target gene prediction using 3 independent miRNA target prediction databases as mentioned in the Method section 2.6. Because our objective was to identify miRNAs with 39UTR binding sites for genes involved in GABAergic neurotransmission, we looked for target genes associated with expression of GABA A and glycine receptor subunits, GABA co-transporters and transporters, and GABA-synthesizing enzymes (Fig. 2C) . In target gene analysis, these differentially expressed miRNAs demonstrated multiple 39UTR binding sites for several members of solute carrier gene families, such as slc6, slc12, slc32, GABA receptor subunit genes, and GABA-synthesizing enzymes. Among the upregulated miRNAs in neonatal-cystitis rats, miR-92b-3p demonstrates multiple complementary binding sites for slc12a5, encoding K 1 -Cl 2 -cotransporter 2 (KCC2) and 1 binding site each for slc32a1 vescicular GABA transporter (VGAT) and GABAsynthesizing enzyme gad1. However, in our preliminary study, zymosan treatment protocols failed to show significant difference in gad 1 expression between experimental and control groups, suggesting that the spinal gad 1 expression is not posttranscriptionally regulated by miR-92b-3p in this rat model of zymosaninduced cystitis.
miR-92b-3p expression in L6-S1 spinal cord for all 3 protocols
Using RT-PCR, we further examined the expression profile of miR-92b-3p in spinal dorsal horns (L6-S1) from rats in protocol 2 and protocol 3 to evaluate whether the induction of cystitis in adulthood also has the similar effect on spinal miRNA expression (Figs. 3A-C) . As seen in neonatal cystitis rats, the relative expression (2 2 DC T ) of miR-92b-3p in neonatal cystitis followed by adult rechallenge and adult cystitis rats was significantly higher compared with saline-treated controls (**p , 0.01, *p , 0.05, respectively vs controls).
We investigated the effect of neonatal cystitis on the expression of miR-92b-3p in LS spinal cord (L6-S1) tissue by ISH. As shown in Figure 3D , the integrated intensity of miR-92b-3p expression in spinal dorsal horn neurons of rats with neonatal cystitis demonstrated a significant upregulation compared with saline-treated controls (**p , 0.01). At the same time, there was a trend towards an increase in miR-92b-3p-positive spinal dorsal horn neurons in neonatal cystitis rats with the number of miR 92b-3p-expressing cells in zymosan group was 34.0 6 8 compared with 22.0 6 1.0 for saline-treated controls, p 5 0.06 vs saline controls.
KCC2 and VGAT are the potential targets for miR-92b-3p
As shown in Figure 4A , target prediction by TargetScan identified 4 binding sites for miR-92b-3p on KCC2's 39UTR region; 227 to 233 (poorly conserved 7mer-1A), 1782 to 1789 (conserved 8 Figure 3 . miR-92b-3p expression in spinal dorsal horn (L6-S1) samples from rats receiving treatment as described in Fig. 1A . Groups include (A) neonatally induced cystitis; (B) neonatal cystitis followed by adult rechallenge; (C) adult cystitis. The ordinate value 2 2 DCT corresponds to the miRNA expression relative to endogenous SNORD-95 expression and is represented as mean 6 SD, n 5 5/group, *p , 0.05, **p , 0.01 vs saline controls. (D) In situ hybridization demonstrates significant upregulation of intensity of miR-92b-3p expression (**p , 0.01 vs saline controls) in neonatal zymosan-treated rats in protocol 1, when examined at P60. The scale bar is 50 mm. miRNA, microRNA. To confirm that 39UTRs of KCC2 and VGAT are the targets for miR-92b-3p, we constructed individual pEZX-MT06 reporter vectors carrying 39UTR regions of either KCC2 or VGAT fused downstream of firefly luciferase gene and performed in vitro transfections of HEK293T cells and dual luciferase reporter assay (Fig. 4C) . HEK293 cells co-transfected with plasmid carrying KCC2 39UTR and MIRDIAN miR-92b-3p mimic exhibited significant reduction in firefly luciferase activity compared with cells co-transfected with the same plasmid and MIRIDIAN miRNA mimic negative control (**p , 0.001 vs control plasmids). The percent reduction in firefly luciferase activity for cells cotransfected with reporter vector carrying KCC2 39UTR and miR92b-3p mimic was 80% in comparison with 100% activity for cells transfected with reporter vector carrying KCC2 39UTR. The luciferase activity of cells co-transfected with vector carrying KCC2 39UTR and miRNA mimic negative control was comparable with cells transfected only with plasmid carrying KCC2 39UTR. For the VGAT gene, cells co-transfected with plasmid carrying VGAT 39UTR and MIRDIAN miR-92b-3p mimic exhibited significant reduction in firefly luciferase activity compared with cells co-transfected with plasmid carrying VGAT 39UTR (Fig. 4C , *p , 0.01 vs VGAT 39UTR plasmid). However, the reduction in luciferase activity was about 50% in comparison with 80% reduction in activity for cells transfected with plasmid carrying KCC2 39UTR. This could be due to the presence of only 1 complementary binding site in the 39UTR region of VGAT transcript, whereas KCC2 carries 4 binding sites for miR-92b-3p in the 39UTR region. As seen with KCC2 39UTR plasmid, the luciferase activity of cells co-transfected with vector carrying VGAT 39UTR and miRNA mimic negative control was comparable with cells transfected only with plasmid carrying VGAT 39UTR (Fig. 4C) .
Downregulation of KCC2 and VGAT in spinal dorsal horn (L6-S1) neurons following zymosan-induced cystitis
We next examined the effect of neonatal and adult zymosan treatments on KCC2 and VGAT gene expression in spinal dorsal horns (L6-S1) using all 3 protocols as described in Figure 1A . The neonatal cystitis group demonstrated a long-term downregulation of KCC2 mRNA in adult spinal cord as measured at P60, which was significantly lower than in saline-treated controls (Fig.  5A , *p , 0.05 vs controls). Neonatal cystitis followed by rechallenge and adult cystitis groups also demonstrated significant downregulation in spinal KCC2 expression compared with saline-treated controls (Figs. 5B and C, *p , 0.05 vs controls). However, no significant difference was observed in VGAT expression in neonatal cystitis rats as compared to salinetreated controls (Fig. 5A) . The rechallenge and adult cystitis groups exhibited significant downregulation in VGAT expression (Figs. 5B and C, *p , 0.05 vs controls). Two-way ANOVA showed no difference in the mean expression levels of KCC2 and VGAT as obtained through quantitative RT-PCR in L6-S1 spinal cord in the 3 different protocols. There was no significant protocol 3 treatment (saline or zymosan) interaction. The long-term upregulation of spinal miR-92b-3p expression in neonatal treatment groups (protocol 1) prompted us to examine the expression of its 2 main target proteins, postsynaptic KCC2 and presynaptic VGAT in the spinal neurons from rats that only received neonatal zymosan or saline treatment (Fig. 5D) . By Western blot analysis, spinal KCC2 appeared as a dimer in the molecular weight range of 122 to 215 KD, and VGAT expression was at the range of 58 to 60 KD (Fig. 5D) . The relative expression of KCC2 to b-actin significantly decreased in cystitis rats (0.70 6 0.23) compared with saline-treated controls (1.29 6 0.25, n 5 3/ group, *p , 0.05). The relative expression of VGAT was also significantly downregulated in cystitis rats (0.558 6 0.14) compared with saline-treated controls (0.913 6 0.14, n 5 3/ group, *p , 0.05).
3.6. miR-92b-3p co-expression with several pre-and postsynaptic g-aminobutyric acid (GABA)-associated proteins
In dual ISH and IHC experiments, miR-92b-3p demonstrated coexpression with its target KCC2 in the spinal (L6) dorsal horn neurons (closed arrows, Fig. 6D ). However, KCC2 staining was predominantly on neuronal membranes with miR-92b-3p present both in the membrane and cytoplasm. The postsynaptic expression of miR-92b-3p is also evident from its coexpression with GABA A-a1 -positive neurons in the spinal cord (closed arrows, Fig. 6H) . At the presynaptic level, miR-92b-3p co-expressed with several VGAT-positive GABAergic boutons (closed arrows, Fig. 6L ). However, the majority of VGAT staining was closely apposed to miR-92b-3p expression (open arrows, Fig. 6L ).
Attenuation of the development of zymosan-induced visceral hyperalgesia following intrathecal lentiviral sponge administration
We extended our study to investigate whether pre-emptive administration of miR-92b-3p sponge could attenuate the development of zymosan-induced visceral hyperalgesia in rats ( Figure 1B) . The representative EMG tracings to CRD (40 and 60 mmHg) before and after zymosan treatment for naïve rats are shown in Figure 7A . Figures 7B and C illustrate preand post-zymosan EMG tracings of rats receiving pre-emptive sponge miR-92b-3p and scramble miRNA, respectively. In naïve rats, postzymosan EMG responses to CRD were significantly higher compared with prezymosan recordings (Fig. 7D, *p , 0 .05, **p , 0.01 vs prezymosan baseline). However, miR-92b-3p inhibitors delivered as lentivirus sponge could attenuate the development of visceral hyperalgesia when administered pre-emptively before inducing cystitis (Fig. 7E) . By contrast, the scramble miRNA delivered through the same route failed to attenuate the EMG responses to CRD as indicated by a significantly higher VMR response to graded CRD following zymosan treatment, (Fig. 7F, *p , 0 .05 vs prezymosan baseline). The 2-way repeated measure ANOVA for lentiviral treatment demonstrated a significant difference between sponge vs naïve (p 5 0.002) and scramble (p 5 0.003).
Attenuation of zymosan-induced referred viscerosomatic hypersensitivity following intrathecal lentiviral sponge administration
Intravesical zymosan administration produced an increase in viscerosomatic hypersensitivity, as indicated by a significant increase in response frequencies when von Frey filaments of increasing forces were applied to the suprapubic region of the abdomen (Fig. 8A, *p , 0.05 vs prezymosan baseline values) . As shown in Figure 8B , the pre-emptive administration of lentiviral sponge could attenuate the zymosan-induced increase in viscerosomatic hypersensitivity and showed comparable responses as prezymosan baseline values; whereas the pre-emptive administration of scramble miRNA failed to attenuate the development of viscerosomatic hypersensitivity (Fig. 8C, * (Fig.  4C , **p , 0.001). Similarly, percentage reduction in luciferase activity of cells transfected with VGAT 39UTR and miR 92b-3p is significantly higher than cells transfected with VGAT and miR control mimic (Fig. 4C, *p , 0.01) . GABA, g-aminobutyric acid; mRNA, microRNA; VGAT, vesicular GABA transporter.
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Intrathecal pre-emptive lentiviral sponge administration attenuates the development of cystitis-induced spinal KCC2 and VGAT downregulation
The spinal cord samples were collected from lentivirus-treated groups for immunostaining of KCC2 and VGAT after the completion of behavioral recordings. The pre-emptive administration of miR-92b-3p sponge resulted in a significant upregulation of KCC2 expression in GFP-positive spinal dorsal horn neurons in L6-S1 segment compared with pre-emptively scramble miRNA-treated rats (Fig. 8D) . Single optical section showing strong membrane KCC2 staining for sponge-treated rats compared with weak staining for scramble miRNA-treated controls (arrows, Fig. 8D ). Similarly, miR-92b-3p sponge administration demonstrated a significant increase in VGAT-positive puncta in the selected ROIs around GFPpositive neurons compared with scramble miRNA-treated rats (Fig. 8E) . Single optical section showing an increase in the number of VGAT-positive puncta around GFP-positive neurons in sponge-treated compared with scramble-miRNA-treated rats (arrows, Fig. 8E ). Quantification of the intensity of membrane KCC2 staining for GFP-positive cells and the number of VGAT-positive puncta around GFP-positive neurons showed an increase for miR-92b-3p sponge-treated rats (Fig.  8F , for KCC2 *p , 0.01, VGAT **p , 0.001 vs scramble miRNA).
Discussion
In the present study, we report for the first time that in experimental models of zymosan-induced cystitis, the increased spinal miR-92b-3p expression contributes to CPP and visceral nociception by downregulating 2 of its target genes: GABAassociated transporters KCC2 and VGAT in LS spinal dorsal horn neurons. Both neonatal and adult bladder inflammation protocols demonstrated a similar increase in spinal miR-92b-3p expression and a subsequent decrease in KCC2 and VGAT gene expression indicating a major role for miR-92b-3p-mediated transcriptional dysregulation of spinal GABAergic transmission in pathophysiology of zymosan-induced cystitis and PBS. Using ISH, we demonstrated a significant upregulation of miR-92b-3p in the spinal dorsal horn neurons of neonatal cystitis rats compared with saline-treated controls. In a subsequent dual ISH and IHC study, we further confirmed the co-expression of miR-92b-3p with targets KCC2 and VGAT in spinal dorsal horn neurons, emphasizing a possible regulatory role of this miRNA on spinal GABAergic transmission both at pre-and post-synaptic levels. We then demonstrated that inhibiting miR-92b-3p expression in L6-S1 spinal neurons by i.t. administration of lentiviral pLSyn-miR-92b-3p sponge (carrying miR-92b-3p inhibitor) upregulates spinal KCC2 and VGAT expression in spinal dorsal horn neurons. In behavioral studies, i.t. administration of lentiviral miR-92b-3p sponge in LS region in rats before inducing cystitis reduced visceral hyperalgesia and referred viscerosomatic hypersensitivity compared with group receiving scramble lentivirus. Considering that we used neuronal synapsin promoter for selective expression of miR-92b-3p sponge, our findings demonstrate the specific relevance of miR-92b-3p-mediated downregulation of GABAergic transmission in the spinal neurons as a major contributor towards the pathophysiology of zymosaninduced CPP. miRNAs have recently emerged as major transcriptional regulators of gene expression and appear to regulate the expression of various receptors and neurotransmitters in the CNS. Several studies support the involvement of miRNAmediated gene regulation in pathophysiology of acute and chronic pain. 1, 4, 8, 12, 18, 23, 30, 31, 40, 42 At the synaptic level, miRNAs specifically target neuronal mRNAs localized near the synapse and modulate input-specific synaptic protein synthesis and neuronal plasticity. 22, 28 We previously reported the involvement of spinal miR-181a in both transcriptional as well as translational repression of spinal GABA Aa-1 receptor subunit expression in adult rats following neonatal bladder inflammation. 35 The miRNA PCR array findings in our present study further validate the presence of common miRNA-mediated gene regulatory mechanisms between zymosan-induced bladder pain and/or cystitis and other neuropathic and inflammatory pain processes. Although previous studies have shown the involvement of miR-92 in posttranscriptional regulation of GABAergic transmission in cerebellar granule neurons and hippocampal memory formation in mice, to our knowledge, this is the first report indicating spinal miR-92b-3p in transcriptional dysregulation of GABAergic transmission and development of visceral hyperalgesia in zymosaninduced cystitis. 2, 38 In a recent study, miR-92a-mediated downregulation of VGAT expression in the hippocampus CA3 region has been implicated as the molecular mechanism of underlying anxiety in patients with Alzheimer disease. 15 Although both miR-92a and miR-92b-3p carry identical complementary binding sites for VGAT 39UTR transcript, however, miR-92a expression was comparable between zymosan-and salinetreated rats in the present study. This could be due to the presence of brain region-specific miRNA biogenesis and the involvement of distinct miRNA-mediated posttranscriptional gene regulatory mechanism for different disease processes.
In the spinal cord, primary afferent neurons from the periphery makes synaptic connection with the projection neurons and interneurons located in superficial laminae I and II and around 25% to 40% of spinal neurons are reported to be GABAergic in laminae I to III. 19, 24, 37 The loss of GABAergic inhibition in painsignaling pathways has been proposed as one of the primary mechanisms for pain-induced hyperalgesia and appear to play a key role in the development of acute to chronic pain. 11, 19 Impaired GABAergic inhibition in the spinal cord has been reported to contribute to neuropathic pain characterized by increased sensitivity to thermal and mechanical stimuli. 25, 32 The mechanism of underlying impaired GABAergic inhibition in pain pathophysiology is not fully understood, but a number of different mechanisms have been proposed, which may include impairment in expression and function of various GABA-associated components both at presynaptic and postsynaptic levels, such as GABA A receptor subunits, co-transporter KCC2, GABA synthesizing enzymes (Gad1 and Gad2), and GABA transporters. 10, 19, 34 Our present findings along with our previous report suggest that the spinal GABAergic impairment in the setting of zymosan-induced PBS is mediated through miRNAmediated epigenetic regulation of various GABA-associated receptors, transporters, and co-transporters both at presynaptic and postsynaptic levels.
The involvement of KCC2-mediated impairment of spinal (Cl 2 ) homeostasis has been reported in rats with chronic water avoidance stress-induced visceral hyperalgesia. 36 Similarly, in a nerve injury model, i.t. delivery of KCC2 using lentiviral vector results in a complete and long-lasting reversal of pain hypersensitivity by restoring Cl 2 homeostasis both at spinal and peripheral levels.
14 Unlike KCC2, the role of VGAT in the pathophysiology of GABA disinhibition is not clearly defined. However, in heterozygous VGAT (6) mice, the thermal nociception and inflammatory pain sensation are greater compared with wild-type (WT) mice, indicating the role of VGAT-mediated inhibitory drive in specific forms of sensory pain processing. 39 In addition, electrophysiological recording of spinal motor neurons from VGAT knockout mice during embryonic day E18.5 also exhibits no spontaneous inhibitory postsynaptic current mediated by GABA. 29 In line with these observations, our present study also suggests that the Several preclinical studies have demonstrated that the exposure to bladder inflammation early in life can cause longterm alteration in sensory pain processing during adulthood. 6, 17, 26 We have recently demonstrated a long-term downregulation of GABA Aa-1 receptor subunit expression in spinal neurons following neonatal cystitis and i.t. administration of GABA A receptor agonist muscimol that failed to attenuate the VMR in these hyperalgesic rats indicating an impairment of postsynaptic GABA transmission. 35 Similarly, we have also shown that the i.t. administration of HZ166, a potent GABA Aa-2 agonist, is ineffective in attenuating both VMR and urinary bladder distension responsive spinal neurons in rats with neonatal cystitis. 10 In the present study, we further demonstrated that the i.t. administration of miR-92b-3p inhibitor can restore the expression of KCC2 and VGAT in spinal neurons and also attenuate the development of visceral hyperalgesia in neonatal zymosan-treated rats. The adult zymosan treatment demonstrated a transient downregulation of both KCC2 and VGAT gene expression and concomitant increase in spinal miR-92b-3p, the day after the induction of cystitis. However, unlike with neonatally treated rats, the adult zymosan treatment failed to demonstrate a prolonged increase in pain sensitivity and downregulation of spinal KCC2 and VGAT expression when tested 6 weeks after zymosan treatment (data not shown).
Accumulating evidence suggests the involvement of miRNAs in the underlying pathophysiology of visceral pain disorders. 41, 42 For example, colonic biopsies from patients with IBS) reveal reduced miR199a/b expression in patients with diarrhea predominant IBS compared with those of normal individuals. 42 Moreover, decreased miR-199 directly correlates with increased colonic TRPV1 expression and inversely with visceral pain scores. The increase in colonic miR-29a expression has been associated with intestinal permeability in IBS patients with chronic abdominal pain. 41 In patients with PBS, overexpression of bladder miR-199a-5p has been linked to impaired urothelial permeability, 18 and bladder miRNAs have also been implicated in the modulation of NK1 receptor expression and the underlying molecular mechanisms of bladder pain syndrome. 31 Although we have not examined the expression pattern of miRNAs in the bladder or colon tissues of cystitis rats, histopathological evaluation of bladder tissues revealed a higher inflammatory cell infiltration, erosion, and edema in rats with neonatal zymosan and adult zymosan rechallenge compared with only adult zymosan exposures, whereas in neonatal zymosan-treated rats without rechallenge bladder histology appeared normal. This finding indicates that underlying Figure 7 . Effect of pre-emptive lentiviral miR-92b-3p sponge and scramble control administration on the development of cystitis-induced colonic hyperalgesia (measured by recording the VMR to CRD in rats, (n 5 7-8/group). The schematic presentation of the treatment protocols is shown in Fig. 1B . Representative EMG tracing of 40 and 60 mmHg of graded CRD of (A) pre-and post-zymosan in naïve rats, (B) pre-and post-zymosan in rats pre-emptively treated with lentiviral sponge miR 92b-3p 2 weeks before zymosan exposures and, (C) pre-and post-zymosan in rats pre-emptively treated with scramble control 2 weeks before zymosan exposures. VMR is represented as percentage normalized EMG response to 60 mm Hg CRD of pretreatment baseline. (D) Three days of intravesicle zymosan produced a significant (*p , 0.05, **p , 0.01 vs prezymosan) increase in VMR to CRD in adult rats, (E) pre-emptive lentiviral sponge miR-92b-3p administration attenuates increasing VMR to CRD seen with only zymosan treatment, (F) pre-emptive lentiviral scramble control administration demonstrates comparable response (*p , 0.05 vs prezymosan) as seen with only zymosan treatment. CRD, colorectal distension; EMG, electromyography; VMR, visceromotor response. morphological changes occur following neonatal exposure, which initiates an enhanced inflammatory response when the bladder is re-exposed to zymosan in adulthood. These heightened bladder histological changes following rechallenge are worth addressing to delineate the mechanism of early-life dependent vulnerability of long-term alteration in visceral sensory system and its contribution towards the development of bladder pain syndrome.
Overall, our study documents spinal GABAergic deregulation as one of the pathophysiologic mechanisms underlying CPP, which may have potential for future development of miRNA-based therapy for interstitial cystitis/PBS. The present results along with our previous findings emphasize that miRNA-mediated downregulation of spinal KCC2, VGAT, and GABA A receptor subtypes in cystitis rats may be a potential factor for increased visceral hypersensitivity and the development of CPP. In in vivo studies, we have also shown that miR-92b-3p inhibitor could be used successfully to dampen visceral hypersensitivity and upregulate KCC2 and VGAT expression in the spinal cord. In the future, miRNA-based strategies may be useful to reverse the GABAergic inhibitory modulation, which appears to be one of the major underlying mechanisms leading to CPP. 
